A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABAA-α5 NAM (basmisanil) on intellectual disability associated with Down syndrome
Goeldner, Celia, Kishnani, Priya S., Skotko, Brian G., Casero, Julian Lirio, Hipp, Joerg F., Derks, Michael, Hernandez, Maria-Clemencia, Khwaja, Omar, Lennon-Chrimes, Sian, Noeldeke, Jana, Pellicer, Sabine, Squassante, Lisa, Visootsak, Jeannie, Wandel, Christoph, Fontoura, Paulo, d’Ardhuy, Xavier Liogier, De La Torre Fornell, Rafael, Glue, Paul, Hoover-Fong, Julie, Uhlmann, Sonja, Malagón Valdez, Jorge, Marshall, Andrew, Martinón-Torres, Federico, Redondo-Collazo, Lorenzo, Rodriguez-Tenreiro, Carmen, Marquez Chin, Valeria, Michel Reynoso, Adriana G., Mitchell, Ed A., Slykerman, Rebecca F., Wouldes, Trecia, Loveday, Sarah, Moldenhauer, Fernando, Novell, Ramon, Ochoa, Cesar, Rafii, Michael S., Rebillat, Anne-Sophie, Sanlaville, Damien, Sarda, Pierre, Shankar, Rohit, Pulsifer, Margaret, Evans, Casey L., Silva, Alexandra M., McDonough, Mary Ellen, Stanley, Maria, McCary, Lindsay M., Vicari, Stefano, Wilcox, William, Zampino, Giuseppe, Zuddas, Alessandro
Published in Journal of neurodevelopmental disorders (05.02.2022)
Published in Journal of neurodevelopmental disorders (05.02.2022)
Get full text
Journal Article
A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABA A -α5 NAM (basmisanil) on intellectual disability associated with Down syndrome
Goeldner, Celia, Kishnani, Priya S, Skotko, Brian G, Casero, Julian Lirio, Hipp, Joerg F, Derks, Michael, Hernandez, Maria-Clemencia, Khwaja, Omar, Lennon-Chrimes, Sian, Noeldeke, Jana, Pellicer, Sabine, Squassante, Lisa, Visootsak, Jeannie, Wandel, Christoph, Fontoura, Paulo, d'Ardhuy, Xavier Liogier
Published in Journal of neurodevelopmental disorders (05.02.2022)
Get full text
Published in Journal of neurodevelopmental disorders (05.02.2022)
Journal Article
A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABAA-[alpha]5 NAM (basmisanil) on intellectual disability associated with Down syndrome
Wouldes, Trecia, Zuddas, Alessandro, Pellicer, Sabine, Redondo-Collazo, Lorenzo, Glue, Paul, Rafii, Michael S, Malagón Valdez, Jorge, Lennon-Chrimes, Sian, d'Ardhuy, Xavier Liogier, De La Torre Fornell, Rafael, Silva, Alexandra M, Mitchell, Ed A, Marshall, Andrew, Stanley, Maria, Hipp, Joerg F, Derks, Michael, Shankar, Rohit, Uhlmann, Sonja, Pulsifer, Margaret, Casero, Julian Lirio, Rebillat, Anne-Sophie, Visootsak, Jeannie, Kishnani, Priya S, Squassante, Lisa, Noeldeke, Jana, Hernandez, Maria-Clemencia, Fontoura, Paulo, Sanlaville, Damien, Zampino, Giuseppe, Goeldner, Celia, Loveday, Sarah, McDonough, Mary Ellen, Khwaja, Omar, Wandel, Christoph, Wilcox, William, Slykerman, Rebecca F, Ochoa, Cesar, Martinón-Torres, Federico, Marquez Chin, Valeria, Evans, Casey L, Michel Reynoso, Adriana G, McCary, Lindsay M, Vicari, Stefano, Skotko, Brian G, Hoover-Fong, Julie, Moldenhauer, Fernando, Sarda, Pierre, Novell, Ramon, Rodriguez-Tenreiro, Carmen
Published in Journal of neurodevelopmental disorders (05.02.2022)
Published in Journal of neurodevelopmental disorders (05.02.2022)
Get full text
Journal Article